<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078375</url>
  </required_header>
  <id_info>
    <org_study_id>115687</org_study_id>
    <secondary_id>R03AG045081</secondary_id>
    <nct_id>NCT02078375</nct_id>
  </id_info>
  <brief_title>The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis</brief_title>
  <acronym>PRESSRA</acronym>
  <official_title>The PRESS RA Study: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>American College of Rheumatology Research and Education Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate if the combination of resistance exercise and protein
      supplementation will increase muscle strength and muscle mass among older individuals with
      rheumatoid arthritis (RA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study proposes a randomized trial to evaluate a tailored 16-week resistance exercise
      program, in combination with protein supplementation, for older individuals with RA. The
      exercise protocol in this study is distinctive because it combines dynamic and isometric
      (static) resistance exercise performed on specialized equipment that can accommodate the
      range of motion limitations frequently encountered in the older RA population. This study
      will also begin to evaluate if additional benefit can be achieved with daily protein
      supplementation
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Funding ended, waiting to secure additional sources
  </why_stopped>
  <start_date type="Actual">February 2014</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>after 16 weeks</time_frame>
    <description>measured by dual-energy X-ray absorptiometry (DEXA) (lean mass vs fat mass)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>after 16 weeks</time_frame>
    <description>measured by hand grip and biodex</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Carbohydrate supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will be enrolled in a twice weekly resistance exercise program. They will receive a carbohydrate supplement to take twice daily (once after exercise).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be enrolled in a twice weekly resistance exercise program. They will receive a twice daily protein supplement (once after exercise).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein</intervention_name>
    <description>whey protein plus casein protein</description>
    <arm_group_label>Protein Supplementation</arm_group_label>
    <other_name>whey protein plus casein protein</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrate (Placebo)</intervention_name>
    <description>The twice daily placebo will consist of a carbohydrate and a small amount of protein</description>
    <arm_group_label>Carbohydrate supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Exercise Program</intervention_name>
    <description>All participants will be enrolled in an individually supervised twice weekly (for 16 weeks) resistance exercise program</description>
    <arm_group_label>Carbohydrate supplement</arm_group_label>
    <arm_group_label>Protein Supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 60-95 years

          -  diagnosis of rheumatoid arthritis

          -  willing to participate in twice weekly exercise sessions

        Exclusion Criteria:

          -  cognitive impairment

          -  recent heart surgery (within past 12 months)

          -  severe kidney disease

          -  use of supplemental oxygen

          -  presence of pacemaker

          -  diabetes that requires insulin for management

          -  allergy to soy or milk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca L. Manno, MD, MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Campus</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2014</study_first_submitted>
  <study_first_submitted_qc>March 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rheumatoid Arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

